24th Annual Perspectives in Urology: Point Counterpoint
The 24th Annual Perspectives in Urology: Point Counterpoint will bring together leading experts to discuss and debate the latest in diagnosis, treatment, and ongoing research in the field or urology. The conference will contain lectures, debates, case presentations, discussions, and interactive question and answer sessions. The use of cutting-edge audience response technology will allow for more fluent interaction among attendees, between attendees and speakers, and for more efficient xchange of knowledge within the symposium space.
This three-day course has been designed to address key questions on potentially practice changing developments in the field of urology, and to provide urologists, trainees, and other health care professionals involved in the diagnosis and management of urologic diseases with the framework to integrate these developments into their daily practice. All educational offerings will enhance patient assessment and outcomes and will include didactic lectures, debates, case presentations, and question and answer sessions.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and CJP Medical Communications. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
MCW designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 14.75 hours of participation for continuing education for allied health professionals.
This activity is designed for and will benefit urologists, urologic oncologists, medical oncologists, radiation oncologists, and other health care professionals involved in the diagnosis and management of urologic diseases.
This educational initiative aims to reach urologists, urologic oncologists, and nurses. Upon completion of this activity, participants will be able to:
- Evaluate the growing use of biomarkers in genitourinary cancer detection
- Implement optimal practices for diagnosis and management of prostate, bladder, and renal cancers
- Integrate available hormonal, cytotoxic and immunotherapeutic agents for advanced and castration-resistant prostate cancer
- Define recent developments in genitourinary disease treatments that can impact patient quality-of-life outcomes
- Assess the options for personalizing treatment and sequencing new therapies in individual patients
Professor of Surgery, Urology and Radiation Oncology
E. David Crawford Endowed Chairin Urologic Oncology
University of Colorado, Denver
Robert E. Donohue, MD
University of Colorado, Denver
Steven E. Finkelstein, MD
21st Century Oncology
Karl J. Kreder, MD, MBA
University of Iowa Hospital and Clinics
Iowa City, IA
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT
Matt T. Rosenberg, MD
Mid Michigan Health Centers
Disclosure of Conflicts of Interest
It is the policy of Medical College of Wisconsin to insure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MCW identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MCW to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
CJP Medical Communications Disclosure
The employees of CJP Medical Communications have no financial relationships to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Medical College of Wisconsin, Carden Jennings Publishing, or the program supporters. Before prescribing any medication, physicians should consult primary references and full prescribing information. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically, and are encouraged to consult appropriate resources for any product or device mentioned in this program.
- 14.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 14.75 Hours of ParticipationHours of Participation credit.